Navigation Links
AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA
Date:11/29/2007

WILMINGTON, Del., Nov. 29 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the United States (US) Food and Drug Administration (FDA) has granted an additional six-month period of exclusivity to market ARIMIDEX(R) (anastrozole) for its licensed breast cancer indications until June 2010. Prior to pediatric exclusivity being granted by the FDA, the patent was due to expire in December 2009.

ARIMIDEX is currently approved in the US for the for the following indications:

-- The adjuvant treatment (treatment following surgery with or without

radiation) of postmenopausal women with hormone receptor positive early

breast cancer (Sub Part H approval granted in 2002, final approval in

2005).

-- The first-line treatment of postmenopausal women with hormone receptor

positive or hormone receptor unknown locally advanced or metastatic

breast cancer (granted in 2000).

-- The treatment of advanced breast cancer in postmenopausal women with

disease progression following tamoxifen therapy. Patients with hormone

receptor-negative disease and patients who did not previously respond

to tamoxifen therapy rarely responded to ARIMIDEX (granted in 1995).

Dr. John Patterson, Executive Director of Development at AstraZeneca said "Pre-clinical and clinical data supported the investigation of the therapeutic potential of ARIMIDEX in pediatric conditions that manifest symptoms resulting from increased estrogen production, for example: gynecomastia in pubertal boys and precocious puberty in girls with McCune-Albright Syndrome (MAS). While pleased to have been able to work with the FDA in investigating the potential benefits of ARIMIDEX in these settings, AstraZeneca will not be seeking an indication in either of these pediatric conditions based on trial results."

In the US, ARIMIDEX sales reached $507 million for the nine months of 2007. ARIMIDEX has a
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AstraZeneca Leads Local Walking Movement
2. AstraZeneca Joins Local Walking Movement
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
5. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
6. AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
7. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
8. Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca
9. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... Americas announces major investment in new technology and personnel ... Medical Answering Service customers. Through a combination of ... provides a seamless transition between a health care provider’s ... patient satisfaction. , Tunstall is pleased to ... expanded facilities and the latest telecommunication software and hardware ...
(Date:5/24/2015)... 24, 2015 Women's Excellence in ... loss. Although it is unclear about the etiology of ... factors such as metabolism, nutritional deficiencies, thyroid abnormalities and ... a comprehensive approach to evaluating the metabolic, nutritional and ... can help patients find a cause for their problem. ...
(Date:5/24/2015)... 24, 2015 The federal court ... ) has scheduled its next monthly Case Management ... litigation. According to court documents filed in the ... Conference will be convened on June 2, 2015, ... Product Liability Litigation - MDL No. 2545) , ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 A ... indicator that the single best option for avoiding cardiovascular ... that fitness level was the single most powerful predictor ... variables such as diabetes and family history of premature ... maintaining lifelong heart and lung fitness. , The Importance ...
(Date:5/23/2015)... NY (PRWEB) May 23, 2015 On ... that, “the company has been the target of ... a part of the company’s ongoing Information Technology (IT) ... health insurers.” , The most notable attack on ... when Anthem Inc., the nation’s second largest health insurer, ...
Breaking Medicine News(10 mins):Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... and minority cancer patients through cancer treatment, called lay ... that prevent them from receiving quality care and achieving ... 2007, at the American Society for Therapeutic Radiology and ... Minority and low-income cancer patients continue to receive inferior ...
... Health & Science University researchers are reporting the discovery ... surgery and radiation therapy is used for patients with ... Surgery and radiotherapy shows an early response benefit. It ... for the first-line treatment, said Clifton David Fuller, M.D., ...
... Oct. 28 Disparities in access to health ... populations from receiving needed cancer services and often ... lasting impact of cancer education geared toward African-Americans, ... (UPMC), in partnership with The Centers for Healthy ...
... Efficiency and ... Treatment Consistency, CHICAGO, ... University of Nebraska Medical Center to save more than 83,percent ... prostate cancer. The automatic segmentation,software developed by BrainLAB replaces manual ...
... advice on safety, proper use , SUNDAY, Oct. 28 (HealthDay ... safety and best use of household cleaners and disinfectants from ... Surface Hygiene Fact Sheet outlines the safe, proper use ... germs can linger and the types of products available for ...
... A newborns chance for surviving a low-risk version of a ... study by Johns Hopkins surgeons. Babies with the condition have ... uncomplicated variant of the condition, where the hole is the ... percent of babies survive it. However the Hopkins findings suggest ...
Cached Medicine News:Health News:Patient navigators help minority, low-income cancer patients get life-saving treatments 2Health News:OHSU researchers: Surgery, radiation gives early survival advantage in bile duct cancer 2Health News:Education program leads to lasting improvement of cancer knowledge in African Americans 2Health News:iPlan(R) Automatic Segmentation Saves 25 Minutes of Treatment Planning Time for Each Prostate Cancer Patient at the University of Nebraska Medical Center 2
(Date:5/21/2015)... 21, 2015 Research and ... of the "Market Assessment of Respiratory Diagnostics ... to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This ... imaging diagnostics market in the United ... . The service provides detailed analysis of the ...
(Date:5/21/2015)... , May 21, 2015  Cardica, Inc. (Nasdaq: CRDC ... Greg Watson , the company,s vice president of operations, ... company,s common stock, at a per share exercise price of ... stock option was granted pursuant to Cardica, Inc.,s Inducement Plan, ... May 2015 under Rule 5653(c)(4) of the Nasdaq Global Market ...
(Date:5/21/2015)... 21. Mai 2015 Dipexium ... ein Unternehmen für Arzneimittel im fortgeschrittenen ... und Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) ... eine wissenschaftliche Posterpräsentation an, welche das ... vorstellt, OneStep-1 und OneStep-2, in der ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Cardica Announces New Employment Inducement Grant 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... (NYSE: JNJ ) said today that Colleen Goggins, ... the Company effective March 1, 2011, after a successful and ... Weldon, Chairman and CEO, said, "Throughout her tenure, Colleen has ... has made major contributions to our success.  We thank Colleen ...
... HAYWARD, Calif., Sept. 16 Solta Medical, Inc. (Nasdaq: ... skin tightening and a market leader in aesthetic skin treatments, ... Fraxel re:store ® Dual ... Fraxel re:store Dual system takes the industry leading fractional laser ...
Cached Medicine Technology:Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis 2Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis 3
... FoamWrap Final Flexion Wraps restore full ... injury or when lost due to arthritic ... breathable, foam-lined material hugs the finger to ... to restore motion. One size. Sold in ...
One splint does it all....
... the physiological causes of minor knee pain ... works in concert with the motion of ... liner and patellar tendon and assisting in ... Semi-rigid plastic support with high density foam ...
... post-operative knee braces are designed to provide ... ,Adjustable and versatile, ROM braces are ... care professionals. The braces are extremely patient-friendly, ... dial combination hinges that allow you to ...
Medicine Products: